BDBM50200819 CHEMBL3938021

SMILES: COc1ccc(CNC(=O)N2[C@H](C)CN(Cc3ccc(o3)C(F)(F)F)c3cnccc3[C@@H]2C)cc1

InChI Key: InChIKey=CNIBHFMXGCXGHJ-SJORKVTESA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50200819   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Voltage-dependent T-type calcium channel subunit alpha-1H (Homo sapiens (Human))	BDBM50200819 (CHEMBL3938021) Show SMILES COc1ccc(CNC(=O)N2[C@H](C)CN(Cc3ccc(o3)C(F)(F)F)c3cnccc3[C@@H]2C)cc1 |r| Show InChI InChI=1S/C25H27F3N4O3/c1-16-14-31(15-20-8-9-23(35-20)25(26,27)28)22-13-29-11-10-21(22)17(2)32(16)24(33)30-12-18-4-6-19(34-3)7-5-18/h4-11,13,16-17H,12,14-15H2,1-3H3,(H,30,33)/t16-,17+/m1/s1	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	24	n/a	n/a	n/a	n/a	n/a	n/a
Actelion Pharmaceuticals Ltd. Curated by ChEMBL					Assay Description Channel blocking activity at recombinant human CaV 3.2 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins ...				J Med Chem 59: 10661-10675 (2016) Article DOI: 10.1021/acs.jmedchem.6b01356 BindingDB Entry DOI: 10.7270/Q2RV0QN8
					More data for this Ligand-Target Pair
Voltage-gated T-type calcium channel (Homo sapiens (Human))	BDBM50200819 (CHEMBL3938021) Show SMILES COc1ccc(CNC(=O)N2[C@H](C)CN(Cc3ccc(o3)C(F)(F)F)c3cnccc3[C@@H]2C)cc1 |r| Show InChI InChI=1S/C25H27F3N4O3/c1-16-14-31(15-20-8-9-23(35-20)25(26,27)28)22-13-29-11-10-21(22)17(2)32(16)24(33)30-12-18-4-6-19(34-3)7-5-18/h4-11,13,16-17H,12,14-15H2,1-3H3,(H,30,33)/t16-,17+/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	13	n/a	n/a	n/a	n/a	n/a	n/a
Actelion Pharmaceuticals Ltd. Curated by ChEMBL					Assay Description Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins ...				J Med Chem 59: 10661-10675 (2016) Article DOI: 10.1021/acs.jmedchem.6b01356 BindingDB Entry DOI: 10.7270/Q2RV0QN8
					More data for this Ligand-Target Pair
Voltage-gated T-type calcium channel (Homo sapiens (Human))	BDBM50200819 (CHEMBL3938021) Show SMILES COc1ccc(CNC(=O)N2[C@H](C)CN(Cc3ccc(o3)C(F)(F)F)c3cnccc3[C@@H]2C)cc1 |r| Show InChI InChI=1S/C25H27F3N4O3/c1-16-14-31(15-20-8-9-23(35-20)25(26,27)28)22-13-29-11-10-21(22)17(2)32(16)24(33)30-12-18-4-6-19(34-3)7-5-18/h4-11,13,16-17H,12,14-15H2,1-3H3,(H,30,33)/t16-,17+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	11	n/a	n/a	n/a	n/a	n/a	n/a
Actelion Pharmaceuticals Ltd. Curated by ChEMBL					Assay Description Channel blocking activity at recombinant human CaV 3.3 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins ...				J Med Chem 59: 10661-10675 (2016) Article DOI: 10.1021/acs.jmedchem.6b01356 BindingDB Entry DOI: 10.7270/Q2RV0QN8
					More data for this Ligand-Target Pair